NEOPLASMA
Article List
Volume 63, 2016, No. 3
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- VALKO-ROKYTOVSKA, M. - BRUCHATA, K. - SIMKOVA, J. - MILKOVICOVA, M. - KOSTECKA, Z.: Current trends in the treatment of malignant melanoma. (p. 333)
- LI, Q. - YUAN, D. - MA, C. - LIU, Y. - MA, L. - LV, T. - SONG, Y.: A new hope: the immunotherapy in small cell lung cancer. (p. 342)
- DING, Z. - XU, F. - TANG, J. - LI, G. - Jiang, P. - TANG, Z. - WU, H.: Physcion 8-O-β-glucopyranoside prevents hypoxia-induced epithelial-mesenchymal transition in colorectal cancer HCT116 cells by modulating EMMPRIN. (p. 351)
- ZHANG, Y. - BAO, C. - MU, Q. - CHEN, J. - WANG, J. - Mi, Y. - SAYARI, A. - CHEN, Y. - GUO, M.: Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells. (p. 362)
- TROJANOWICZ, B. - SEKULLA, C. - DRALLE, H. - HOANG-VU, C.: Expression of ARE-binding proteins AUF1 and HuR in follicular adenoma and carcinoma of thyroid gland. (p. 371)
- WU, Y. - Sun, B. - SHI, W. - NI, L. - CHEN, J. - CAI, G. - SHI, J.: OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas. (p. 378)
- SIMA, J. - ZHANG, B. - SIMA, X. - MAO, Y.: Overexpression of BTG2 suppresses growth, migration, and invasion of human renal carcinoma cells in vitro. (p. 385)
- CHEN, X. - WU, R. - WANG, S. - DUAN, Q. - XUAN, Y.: RNA-Seq analysis for the potential targets and molecular mechanisms of 17 β-estradiol in squamous cell lung carcinoma. (p. 394)
- KORABECNA, M. - GERYK, J. - HORA, M. - STEINER, P. - SEDA, O. - Tesar, V.: Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas. (p. 402)
- LI, Q. - LI, X. - WANG, C.: Uc.206 regulates cell proliferation and apoptosis by targeting P53 in cervical cancer cells. (p. 411)
- TENG, Y. - FAN, Y. - MU, N. - ZHAO, J. - SUN, F. - WANG, K.: Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma. (p. 419)
- POHLODEK, K. - BOZIKOVA, S. - MECIAROVA, I. - MUCHA, V. - BARTOVA, M. - ONDRIAS, F.: Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes. (p. 427)
- RICHTER, I. - JIRASEK, T. - DVORAK, J. - CERMAKOVA, E. - BARTOS, J.: The prognostic significance of epidermal growth factor receptor expression in patients with anal carcinoma. (p. 435)
- YUAN, C. - LI, H. - ZHU, L. - LIU, Z. - ZHOU, J. - SHU, Y.: Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. (p. 442)
- SACZKO, J. - PILAT, J. - CHOROMANSKA, A. - REMBIALKOWSKA, N. - BAR, J. - KAMINSKA, I. - ZALEWSKI, J. - KULBACKA, J.: The effectiveness of chemotherapy and electrochemotherapy on ovarian cell lines in vitro. (p. 450)
- VOLEJNIKOVA, J. - JAROSOVA, M. - POSPISILOVA, D. - NOVAK, Z. - VRBKOVA, J. - HAJDUCH, M. - MIHÁL, V.: Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic. (p. 456)
- VOBORIL, R. - RYCHTEROVA, V. - VOBORILOVA, J. - KUBECOVA, M. - FANTA, J. - DVORAK, J.: NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival. (p. 462)
- FIALA, O. - PEŠEK, M. - FINEK, J. - RACEK, J. - MINARIK, M. - BENESOVA, L. - BORTLICEK, Z. - SOREJS, O. - KUCERA, R. - TOPOLCAN, O.: Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib. (p. 471)
- KAIRA, K. - TOYODA, M. - SHIMIZU, A. - Imai, H. - Sakakura, K. - NIKKUNI, O. - SUZUKI, M. - IIJIMA, M. - ASAO, T. - CHIKAMATSU, K.: Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma. (p. 477)
- KALFUSOVA, A. - HILSKA, I. - KRSKOVA, L. - KALINOVA, M. - LINKE, Z. - KODET, R.: Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior. (p. 484)